As shown in Figure 4E, treatment with NNU546 reduced the density of CD31 (green color), α-SMA (red color) and the number of endothelial cells and surrounding pericytes in tumor tissues, further confirming the in vivo anti-tumor and anti-angiogenesis activities of NNU546 in MM. Here, PECAM1 is linked to Miyoshi myopathy.